| Literature DB >> 30270959 |
Amanda E Halliburton1, Matthew S Fritz2.
Abstract
The use of anabolic-androgenic steroids (AAS) is problematic for youth because of negative effects such as reduced fertility, increased aggression and exposure to toxic chemicals. An effective programme for addressing this problem is Adolescents Training and Learning to Avoid Steroids (ATLAS). This secondary analysis expands prior research by identifying prominent mechanisms of change and highlighting key longitudinal processes that contributed to the success of ATLAS. The current sample consists of high-school football players (N = 1.068; M age = 15.25) who began ATLAS in grades nine through eleven and participated in booster sessions for two years post-baseline. Knowledge of AAS effects, belief in media ads, reasons not to use AAS, perceived severity of and susceptibility to AAS effects and ability to resist drug offers were critical mediators of the relations between ATLAS and outcomes. Modern applications of the ATLAS programme are also discussed.Entities:
Keywords: Steroids; adolescents; health behaviour; mediation; prevention
Year: 2017 PMID: 30270959 PMCID: PMC6156000 DOI: 10.1080/02673843.2017.1344928
Source DB: PubMed Journal: Int J Adolesc Youth
ATLAS constructs: mediators and outcome variables.
| Mediators | Variable name | Rating scale | Sample item |
|---|---|---|---|
| Perceived coach tolerance of AAS use | CCH | 1–7 | I have talked with my coaches about alternatives to AAS use |
| Reasons for not using AAS | CON | 0–14 | ‘Afraid of becoming addicted,’ ‘because it is cheating,’ etc. |
| Knowledge of the effects of AAS | KNW | 0–18 | ‘Improve physically,’ ‘more arguments and fights,’ etc. |
| Belief in media advertisements | MED | 1–7 | Products advertised in muscle magazines do what they claim |
| Normative beliefs about AAS use | NRM | 0–11 | Out of every 100 HS football players at your school, how many do you think have ever used AAS, even once? |
| Peers as an information source | PER | 1–7 | Team leaders teach me about drug prevention |
| Perceived peer tolerance of AAS use | PTL | 1–7 | My teammates don’t care if I use AAS |
| Reasons for using AAS | PRO | 0–9 | ‘Get stronger,’ ‘become a better athlete,’ etc. |
| Ability to turn down offers of drugs | RES | 1–7 | I could turn down a weight lifter offering me AAS |
| Perceived severity of AAS Use | SEV | 1–7 | The bad effects of AAS go away when you stop using them |
| Perceived susceptibility to the effects of AAS | SUS | 1–7 | I would have no bad side effects from using AAS |
| Team as an information source | TEM | 1–7 | Being on the football team has improved my health |
|
| |||
| Outcome variables | Variable name | Rating scale | Sample item |
|
| |||
| Intent to use AAS | INT | 1–7 | I intend to use AAS |
| Nutrition behaviours | NUT | 1–7 | My diet has less than 30% of calories from fat |
| Strength training self-efficacy | STR | 1–7 | I know how to train with weights to become stronger |
Note: All scales are constructed such that a higher number reflects a greater or higher amount of the construct.
Figure 1Conceptual model of AAS use based on the three models utilized in the ATLAs programme (Health Belief Model, Social Learning Theory and Theory of Planned Behaviour).
Descriptive statistics for mediators and outcome variables at each time point.
| No. of items | 0 months | 3 months | 12 months | 15 months | 21 months (seniors) | 24 months | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| Construct | |||||||||||||
| CCH | 3 | .642 | 2.14(1.23) | .780 | 2.10(1.33) | .769 | 2.09(1.37) | .790 | 2.20 (1.44) | .778 | 2.12(1.27) | .693 | 2.22 (1.36) |
| CON | 14 | .846 | 6.89 (3.53) | .887 | 7.28 (4.02) | .900 | 7.13(4.19) | .891 | 6.63(4.11) | .875 | 5.82 (3.85) | .907 | 6.92 (4.35) |
| INT | 5 | .919 | 1.72(1.26) | .920 | 1.71 (1.15) | .917 | 1.72 (1.22) | .922 | 1.74(1.21) | .928 | 1.80(1.19) | .956 | 1.89(1.41) |
| KNW | 18 | .895 | 10.21 (4.53) | .921 | 11.77 (4.99) | .923 | 11.66 (4.78) | .942 | 11.79 (4.90) | .948 | 11.86 (4.92) | .955 | 11.20 (5.30) |
| MED | 3 | .750 | 2.81 (1.26) | .800 | 2.57(1.29) | .812 | 2.65(1.35) | .847 | 2.50(1.41) | .817 | 2.40 (1.27) | .831 | 2.70(1.35) |
| NRM | 3 | .824 | 2.51 (1.66) | .796 | 2.23 (1.55) | .820 | 2.30(1.61) | .855 | 1.90 (1.44) | .835 | 1.90 (1.38) | .812 | 2.11 (1.62) |
| NUT | 7 | .809 | 3.98(1.13) | .818 | 4.19(1.09) | .805 | 4.08 (1.12) | .814 | 4.15(1.16) | .881 | 4.12(1.30) | .831 | 4.05 (1.20) |
| PER | 3 | .844 | 4.48 (1.54) | .885 | 4.91 (1.60) | .863 | 4.86 (1.59) | .884 | 5.11 (1.58) | .893 | 5.12(1.67) | .872 | 4.96 (1.47) |
| PTL | 5 | .921 | 2.99 (1.79) | .923 | 3.04 (1.82) | .900 | 3.40 (1.86) | .892 | 3.35(1.82) | .854 | 3.84 (1.69) | .897 | 3.70 (1.86) |
| PRO | 9 | .879 | 1.44 (2.29) | .866 | 1.15(2.06) | .883 | 0.94 (1.92) | .848 | 0.78(1.71) | .906 | 0.68 (1.79) | .830 | 2.34(2.30) |
| RES | 4 | .882 | 5.96 (1.39) | .897 | 5.96(1.35) | .867 | 5.97 (1.36) | .911 | 5.90 (1.47) | .933 | 6.20(1.22) | .918 | 5.92 (1.48) |
| SEV | 3 | .814 | 5.80 (1.26) | .822 | 5.89 (1.26) | .827 | 5.74(1.30) | .831 | 5.79(1.28) | .831 | 5.80 (1.24) | .842 | 5.75(1.38) |
| SUS | 3 | .713 | 6.07(2.12) | .757 | 6.13(2.23) | .760 | 6.04 (2.20) | .772 | 5.92 (2.33) | .815 | 5.78 (2.27) | .753 | 6.13(2.28) |
| STR | 6 | .883 | 5.64(1.15) | .900 | 5.85 (1.07) | .919 | 5.91 (1.16) | .906 | 5.88(1.15) | .908 | 6.10(1.06) | .921 | 5.90(1.16) |
| TEM | 3 | .769 | 5.53(1.13) | .838 | 5.66(1.20) | .801 | 5.74(1.17) | .815 | 5.63 (1.29) | .772 | 5.82(1.14) | .823 | 5.70(1.24) |
Notes:Three variables had significant differences between the control and experimental groups at baseline: MED (t [1036] = 2.82; p = .0049), PER (t [1043] = 2.11; p = .0350), and STR (t [983] = 3.69; p = .0002). In all three cases, the control group had a higher score than the experimental group. In the original study, ATLAS participants achieved significant change in the expected directions on all three variables compared to the control group (Goldberg, Elliot, Clarke, MacKinnon, Moe, et al., 1996). Differences may be due to the fact that schools were assigned to condition but students were analyzed individually.
Figure 2Simplified final longitudinal model of the ATLAS programmes effects, with path coefficients and standard errors.
Notes: Variable names correspond to abbreviations in Table 1. Variable numbers correspond to time point (i.e. 0, 3, 12, 15 or 24 months) as shown in Table 2. Also, though not displayed here, all variables occurring at the same time were correlated. Variables measured at 3 months or later were regressed onto prior time points (except baseline; model fit was compared with and without baseline included and no noteworthy differences were observed between the two versions, so baseline measures were omitted) as shown, where applicable. Only the significant indirect effects from the final mediation model are shown to maximize readability of this figure. Dash–dotted lines represent paths added based on modification indices.
significant total and indirect effects in final model.
| Effect | Unstandardized coefficient (standard error) | 95% confidence interval for unstandardized coefficient | Standardized coefficient (standard error) |
|---|---|---|---|
| Total effect on intent to use AAS (IN24) | −0.028 (0.013) | (−0.058, −0.006) | −0.011 (0.005) |
| ATLAS→CON3→RES12→INT24 | −0.005 (0.003) | (−0.015, −0.001) | −0.002 (0.001) |
| ATLAS→CON3→CON15→INT24 | −0.011 (0.006) | (−0.029, −0.002) | −0.004 (0.002) |
| ATLAS→KNW3→SEV12→SEV15→INT24 | −0.005 (0.003) | (−0.013, −0.001) | −0.002 (0.001) |
| ATLAS→CON3→SEV12→SEV15→INT24 | −0.004 (0.003) | (−0.014, −0.001) | −0.002 (0.001) |
| ATLAS→MED3→SUS12→RES15→INT24 | −0.002 (0.001) | (−0.007, −0.001) | −0.001 (0.001) |
| Total effect on strength training self-efficacy (STR24) | 0.040 (0.015) | (0.012, 0.074) | 0.018 (0.007) |
| ATLAS→KNW3→STR24 | 0.027 (0.013) | (0.008, 0.064) | 0.012 (0.006) |
| ATLAS→KNW3→SEV12→SEV15→STR24 | 0.002 (0.001) | (0.001, 0.007) | 0.001 (0.001) |
Note: 95% confidence intervals were created using the bias-corrected bootstrap.